REFERENCES
- Baraitser, M. and Preece, M. A. (1983). The Rubenstein-Taybi syndrome: occurrence in two sets of identical twins. Clinical Genetics, 23, 318–320.
- Gorlin, R. J., Cohen, M. M.Jnr. and Hennekam, R. C. M. (2001). Syndromes of the Head and Neck, 4th Ed. Oxford: Oxford University Press.
- Hellings, J. A., Hossain, S., Martin, J. K. and Baratang, R. R. (2000). Psychopathology, GABA, and the Rubenstein-Taybi syndrome: a review and case study. American Journal of Medical Genetics, 114, 190–5.
- Levitas, A. S. and Reid, C. S. (1998). Rubinsteain-Taybi syndrome and psychiatric disorders. Journal of Intellectual Disability Research, 42,284–292.
- McCracken, J. T., McGough, J. and Shah, B. (2002). Risperidone in children with au-tism and serious behavioral problems. New England Journal of Medicine, 347, 314–321.
- Petrij, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C. M., Masuno, M., Tommerup, N., Van Ommen, G. B., Goodman, R. H., Peters, D. J. M. and Breuning, M. H. (1995). Rubenstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature, 376, 348–351.
- Petrij, F., Giles, R. H., Breuning, M. H. and Hennekam, R. C. M. (2001). The Rubenstein-Taybi Syndrome. In: Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Bogelstein, B. and Childs, B. (Eds.). The Metabolic and Molecular Basis of Inherited Disease (pp 6167–6182). New York: McGraw-Hill.
- Purdon, S. E., Lit, W., Labelle, A. and Jones, B. D. (1994). Risperidone in the treatment of pervasive development disorder. Canadian Journal of Psychiatry, 39, 400–405.
- Robinson, T. W. and Preece, M. A. (1993). Monozygotic twins concordant for Rubenstein-Taybi syndrome and implications for genetic counselling. American Journal of Medical Genetics, 45, 671–673.
- Rubenstein, J. H. and Taybi, H. (1963). Broad thumbs, toes and facial abnormalities. American Journal of Mental Retardation, 105, 588–608.
- Sabaratnam, M. (1995). Response of patients with learning disabilities and autistic spectrum disorders to risperidone. Journal of Drug Development in Clinical Practice, 2, 7–10.
- Schopler, E., Reichler, M. D. and Renner, R. R. (1998). The Childhood Autism Rating Scale. Los Angeles, CA: Western Psychological Services.
- Sparrow, S. S., Balla, D. A. and Cicchetti, D. V. (1984). Vineland Adaptive Behaviour Scales. (A revision of the Vineland Social Maturity Scale by Doll, E. A.). Circle Pines, MN: American Guidance Service, Inc.
- Stevens, C. A., Hennekam, R. C. and Blackburn, B. L. (1990). Growth in the Rubenstein-Taybi syndrome. American Journal of Medical Genetics Supplement, 6, 51–55.
- Wallerstein, R., Anderson, C. E., Hay, B., Gupta, P., Gibas, L., Ansari, K., Cowchock, F. S., Weinblatt, V., Reid, C., Levitas, A. and Jackson, L. (1997). Submicroscopic deletions at 16p13.3 in Rubenstein-Taybi syndrome. Journal of Medical Genetics, 34,203–206.